Find a Tender · Contract
Newmedica
A public procurement published by NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board via Find a Tender.
- —
- Award value
- —
- Tender value
- 1
- Suppliers
- 1
- Awards
- 1
- Notices
- Contract
- Stage
Overview
The service will provide routine elective secondary care services for patients in the following specialities • Ophthalmology • Potential for community Age-related Macular Degeneration/Glaucoma monitoring where specifically agreed in advance by the commissioner • Diagnostics procedures forming part of an agreed pathway • Direct access to diagnostics procedures, where this has been specifically agreed by the Commissioner • Cataract, Yag and Oculoplastics
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- complete
- CPV classification
- 85121281 — Ophthalmologist services
- Currency
- GBP
- Total award value
- —
- Tender value
- —
- First published
- 5 Nov 2024
- Last updated
- 5 Nov 2024
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| New Medical Systems Ltd | 06211226 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board
FAQs about this procurement
Who is the buyer for "Newmedica"?
Newmedica is a UK public-sector procurement published by NHS Bristol, North Somerset and South Gloucestershire Integrated Care Board via Find a Tender.
Has "Newmedica" been awarded?
Yes — 1 award is recorded. The current lifecycle stage is "Contract".
Which suppliers are involved in "Newmedica"?
1 supplier is linked: New Medical Systems Ltd.
When was "Newmedica" published?
It was first published on 5 Nov 2024 and last updated on 5 Nov 2024, across 1 notice.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable